ImmunoGen, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$8.6M
Doctors Paid
1,928
Transactions
3,800
2024 Total
$883,471
Payment Breakdown by Category
Research$7.3M (84.5%)
Consulting$223,827 (2.6%)
Food & Beverage$120,510 (1.4%)
Travel$84,896 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $7.3M | 449 | 84.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $879,821 | 113 | 10.2% |
| Consulting Fee | $223,827 | 101 | 2.6% |
| Food and Beverage | $120,510 | 2,876 | 1.4% |
| Travel and Lodging | $84,896 | 253 | 1.0% |
| Grant | $24,750 | 7 | 0.3% |
| Education | $30.86 | 1 | 0.0% |
Payments by Type
Research
$7.3M
449 transactions
General
$1.3M
3,351 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| MIRV/BEV serous endometrial cancer | $1.6M | 0 | 20 |
| A Phase 1b/2 Study of IMGN632 as Monotherapy or Combination With Venetoclax and/or Azacitidine for Patients With CD123-Positive Acute Myeloid Leukemia | $1.5M | 0 | 53 |
| MIRV/carboplatin neo-adjuvant therapy in newly diagnosed ovarian cancer | $1.2M | 0 | 13 |
| A Phase 1/2, Multi-center, Open-label Study of IMGN632 Monotherapy Administered Intravenously in Patients With CD123-positive Acute Myeloid Leukemia and Other CD123-positive Hematologic Malignancies | $1.1M | 0 | 60 |
| A Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression (PICCOLO) | $448,807 | 0 | 154 |
| A Phase 1/2, First-in-Human, Open-Label, Dose-Escalation and Expansion Study of IMGC936 (Anti-ADAM9 Antibody Drug Conjugate) in Patients With Advanced Solid Tumors | $299,463 | 0 | 42 |
| Single agent MIRV in high grade serous endometrial cancer | $259,050 | 0 | 5 |
| Multicenter, Open-label, ph 2 Study of Carboplatin Plus Mirvetuximab Soravtansine Followed by Mirvetuximab Soravtansine Continuation in FRa Positive, Recurrent Platinum-sensitive, High-grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Following 1 Prior Line of Platinum-based Chemotherapy | $251,947 | 0 | 35 |
| MIRV olaparib in 2nd line PSOC | $248,800 | 0 | 3 |
| A Phase 1, First-in-Human, Open-Label, Dose-Escalation and Expansion Study of IMGN151 (Anti-FRa Antibody-drug Conjugate) in Adult Patients With Recurrent Endometrial Cancer and Recurrent, High-Grade Serous Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers | $139,033 | 0 | 34 |
| MIRV/olaparib in 2ndline PSOC | $126,888 | 0 | 1 |
| Endometrial cancer tumor bank | $83,456 | 0 | 1 |
| SORAYA: A Phase 3, Single Arm Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression | $54,871 | 0 | 24 |
| Pvek IST | $41,318 | 0 | 1 |
| MIRASOL: A Randomized, Open-label, Phase 3 Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression | $5,000 | 0 | 3 |
Payments by Medical Specialty
| Specialty | Total Paid | Doctors | Avg/Doctor |
|---|---|---|---|
| Pediatrics | $544,002 | 4 | $136,000 |
| Gynecologic Oncology | $338,471 | 180 | $1,880 |
| Obstetrics & Gynecology | $149,874 | 137 | $1,094 |
| Hematology & Oncology | $49,065 | 374 | $131.19 |
| Internal Medicine | $39,769 | 127 | $313.14 |
| Medical Oncology | $34,001 | 107 | $317.77 |
| Hematology | $23,235 | 48 | $484.06 |
| Women's Health | $20,297 | 32 | $634.27 |
| Student in an Organized Health Care Education/Training Program | $13,284 | 44 | $301.91 |
| Family | $11,001 | 194 | $56.71 |
| Physician Assistant | $10,557 | 132 | $79.98 |
| Nurse Practitioner | $10,338 | 165 | $62.66 |
| Ophthalmology | $9,485 | 17 | $557.91 |
| Reproductive Endocrinology | $9,204 | 1 | $9,204 |
| Adult Health | $9,077 | 58 | $156.51 |
| Optometrist | $6,471 | 21 | $308.15 |
| Hospitalist | $6,086 | 5 | $1,217 |
| General Acute Care Hospital | $5,974 | 2 | $2,987 |
| Registered Nurse | $5,144 | 20 | $257.20 |
| Specialist | $1,836 | 44 | $41.73 |
| Medical | $1,730 | 28 | $61.80 |
| Surgical | $1,162 | 14 | $83.03 |
| Acute Care | $1,092 | 28 | $38.99 |
| Anatomic Pathology | $1,005 | 3 | $335.14 |
| Radiation Oncology | $897.13 | 25 | $35.89 |
| Gerontology | $798.49 | 20 | $39.92 |
| Surgery | $613.29 | 8 | $76.66 |
| Primary Care | $555.21 | 9 | $61.69 |
| Oncology | $524.40 | 12 | $43.70 |
| Gynecology | $479.18 | 7 | $68.45 |
| General Practice | $300.41 | 4 | $75.10 |
| Family Medicine | $232.21 | 5 | $46.44 |
| Obstetrics | $197.84 | 3 | $65.95 |
| Surgical Oncology | $178.32 | 5 | $35.66 |
| Corneal and Contact Management | $153.22 | 2 | $76.61 |
| Women's Health Care, Ambulatory | $146.55 | 1 | $146.55 |
| Technician/Technologist | $139.25 | 1 | $139.25 |
| Cornea and External Diseases Specialist | $136.14 | 1 | $136.14 |
| Thoracic Surgery (Cardiothoracic Vascular Surgery) | $126.94 | 1 | $126.94 |
| Body Imaging | $125.00 | 1 | $125.00 |
| Professional | $125.00 | 1 | $125.00 |
| Physical Medicine & Rehabilitation | $110.81 | 1 | $110.81 |
| Diagnostic Radiology | $69.63 | 3 | $23.21 |
| Psychiatric/Mental Health | $66.40 | 3 | $22.13 |
| Diagnostic Ultrasound | $64.69 | 1 | $64.69 |
| Gastroenterology | $61.80 | 3 | $20.60 |
| Hospice and Palliative Medicine | $59.02 | 3 | $19.67 |
| Neuroscience | $56.29 | 1 | $56.29 |
| Emergency Medicine | $54.78 | 2 | $27.39 |
| Neurology | $53.19 | 1 | $53.19 |
| Genetic Counselor, MS | $52.50 | 1 | $52.50 |
| Infusion Therapy | $29.86 | 1 | $29.86 |
| Physical Therapist | $26.21 | 1 | $26.21 |
| Adult Medicine | $26.00 | 1 | $26.00 |
| Colon & Rectal Surgery | $25.74 | 1 | $25.74 |
| Pulmonary Disease | $23.87 | 1 | $23.87 |
| Urology | $23.58 | 1 | $23.58 |
| Neuroradiology | $22.83 | 1 | $22.83 |
| Critical Care Medicine | $22.27 | 1 | $22.27 |
| Cardiovascular Disease | $21.95 | 1 | $21.95 |
| Chiropractor | $19.78 | 1 | $19.78 |
| Psychiatry | $18.81 | 1 | $18.81 |
| Family Health | $18.38 | 1 | $18.38 |
| Emergency | $17.63 | 1 | $17.63 |
| Pediatric Hematology-Oncology | $17.55 | 1 | $17.55 |
| Anatomic Pathology & Clinical Pathology | $16.10 | 1 | $16.10 |
Top Paid Doctors — Page 3
| Doctor | Specialty | Location | Total | 2023 |
|---|---|---|---|---|
| Kevin Brader, Md, MD | Gynecologic Oncology | Wyoming, MI | $2,948 | $0 |
| Dr. Daniel Deangelo, M.d.,Ph.d, M.D.,PH.D | Hematology & Oncology | Boston, MA | $2,940 | $0 |
| Eunice Wang, Md, MD | Hematology | Buffalo, NY | $2,940 | $0 |
| Naveen Pemmaraju, M.d, M.D | Student in an Organized Health Care Education/Training Program | Houston, TX | $2,940 | $0 |
| Keith Pratz, M.d, M.D | Hematology & Oncology | Philadelphia, PA | $2,940 | $0 |
| Dr. Naval Daver, Mbbs, MBBS | Hematology & Oncology | Houston, TX | $2,940 | $0 |
| Gabriel Mannis, Md, MD | Internal Medicine | Stanford, CA | $2,940 | $0 |
| Barbara Buttin, M.d, M.D | Gynecologic Oncology | Zion, IL | $2,789 | $0 |
| Kathryn Lyle | Women's Health | Birmingham, AL | $2,416 | $0 |
| Ms. Vivian Ruszkiewicz, Cnp, CNP | Women's Health | Columbus, OH | $2,406 | $0 |
| Theresa Hohertz, Arnp, ARNP | Nurse Practitioner | Des Moines, IA | $2,372 | $0 |
| Thomas Herzog, M.d, M.D | Gynecologic Oncology | Cincinnati, OH | $2,291 | $0 |
| Debra Richardson, M.d, M.D | Gynecologic Oncology | Oklahoma City, OK | $2,271 | $0 |
| Dr. Nathalie Mckenzie, Md, MD | Gynecologic Oncology | Orlando, FL | $2,250 | $0 |
| Dr. Joshua Cohen, M.d, M.D | Obstetrics & Gynecology | Irvine, CA | $2,181 | $0 |
| Dr. Michael Mchale, Md, MD | Gynecologic Oncology | La Jolla, CA | $2,181 | $0 |
| Robert Coleman, M.d, M.D | Gynecologic Oncology | Houston, TX | $2,181 | $0 |
| Shannon Westin, Md, MD | Obstetrics & Gynecology | Houston, TX | $2,009 | $0 |
| Dr. Brian Slomovitz, M.d, M.D | Gynecologic Oncology | Fort Lauderdale, FL | $1,662 | $0 |
| Ms. Kelly Ball, Whnp, WHNP | Women's Health | Saint Louis, MO | $1,645 | $0 |
| Dr. Robert Weaver, Md, MD | Hematology | Tampa, FL | $1,639 | $0 |
| Dr. Marilyn Huang, Md, MD | Obstetrics & Gynecology | Charlottesville, VA | $1,594 | $0 |
| Floortje Backes, Md, MD | Obstetrics & Gynecology | Hilliard, OH | $1,569 | $0 |
| Dr. Rebecca Arend, M.d, M.D | Gynecologic Oncology | Birmingham, AL | $1,513 | $0 |
| Dr. Matthew Powell, Md, MD | Gynecologic Oncology | Saint Louis, MO | $1,479 | $0 |
About ImmunoGen, Inc.
ImmunoGen, Inc. has made $8.6M in payments to 1,928 healthcare providers, recorded across 3,800 transactions in the CMS Open Payments database. In 2024, the company paid $883,471. The top product by payment volume is Elahere ($4.3M).
Payments were distributed across 66 medical specialties. The top specialty by payment amount is Pediatrics ($544,002 to 4 doctors).
Payment categories include: Food & Beverage ($120,510), Consulting ($223,827), Research ($7.3M), Travel & Lodging ($84,896).
ImmunoGen, Inc. is associated with 1 products in the CMS Open Payments database.